Go to  Advanced Search

Old drugs in a new light : investigating the gold Rheumatoid Arthritis medications as novel inhibitors of neuroinflammation

Show simple item record

dc.contributor.author Madeira, Jocelyn Marie
dc.date.accessioned 2012-11-28T18:37:47Z
dc.date.available 2012-11-28T18:37:47Z
dc.date.copyright 2012 en_US
dc.date.issued 2012-11-28
dc.identifier.uri http://hdl.handle.net/2429/43622
dc.description.abstract Several degenerative disorders of the central nervous system including Alzheimer’s and Parkinson’s diseases are characterized by chronic inflammation. The main contributors to this inflammation are glial cells, including microglia and astrocytes. Even though they are normally protective, disease specific stimuli can activate glial cells to start secreting neurotoxic molecules. There is no effective treatment for neurodegenerative diseases, though it is hypothesized that reducing neuroinflammation may diminish neuronal loss. Chronic use of non-steroidal anti-inflammatory drugs (NSAIDs) has been linked with lower incidence of neurodegenerative disorders, though mixed results have been obtained in clinical trials of NSAIDs when these drugs are used for treatment of established disease. Gold thiol compounds, including aurothiomalate, aurothioglucose, and auranofin, comprise another class of medications effective at reducing peripheral inflammation in rheumatoid arthritis patients. Their effects on neuroinflammation are unknown. In this thesis I demonstrate that 0.1 – 5 µM auranofin, but not the other gold thiol compounds, inhibits human microglia and astrocyte-mediated neurotoxicity in vitro. The anti-neurotoxic properties of auranofin are selective; treatment with auranofin does not inhibit expression or secretion of several cytokines by glia but does upregulate heme-oxygenase (HOX)-1. Interestingly, low micromolar concentrations of auranofin directly protect neuronal cells from toxicity induced by hydrogen peroxide or stimulated glial supernatants, possibly through the upregulation of HOX-1. Lastly, laser ablation inductively coupled plasma mass spectrometry (LA-ICP-MS) was used to demonstrate that auranofin reaches low micromolar concentrations in mouse brains following daily oral administration for one week. Since auranofin can protect against neuroinflammation by inhibiting glial toxicity and is directly neuroprotective, it may be useful in neurodegenerative diseases where sustained inflammation contributes to disease progression including neuronal loss. en_US
dc.language.iso eng en_US
dc.publisher University of British Columbia en
dc.title Old drugs in a new light : investigating the gold Rheumatoid Arthritis medications as novel inhibitors of neuroinflammation en_US
dc.type Electronic Thesis or Dissertation en
dc.degree.name Master of Science - MSc en_US
dc.degree.discipline Biology en_US
dc.degree.grantor University of British Columbia en
dc.date.graduation 2013-05 en_US
dc.degree.campus UBCO en_US
dc.description.scholarlevel Graduate en


Files in this item

Files Size Format Description   View
ubc_2013_spring_Madeira_Jocelyn.pdf.pdf 1.673Mb Adobe Portable Document Format   View/Open
 

This item appears in the following Collection(s)

Show simple item record

All items in cIRcle are protected by copyright, with all rights reserved.

UBC Library
1961 East Mall
Vancouver, B.C.
Canada V6T 1Z1
Tel: 604-822-6375
Fax: 604-822-3893